Exercise & Muscle
    Retatrutide

    Best Exercise Plan for Retatrutide Users

    The right exercise program amplifies retatrutide's fat-burning power while protecting the lean muscle that keeps your metabolism healthy. Here is a structured weekly plan designed specifically for patients on the triple agonist.

    Published: April 3, 202615 min read

    Retatrutide delivers extraordinary weight loss -- up to 24% of body weight in Phase 2 trials (Jastreboff et al., NEJM 2023). But the medication handles the caloric deficit side of the equation. Exercise handles something equally important: ensuring that the weight you lose is overwhelmingly fat, not muscle. Without a structured exercise plan, you risk losing the metabolically active tissue that keeps your metabolism running efficiently long after you stop the medication.

    This exercise plan is designed for retatrutide users at any fitness level. It prioritizes muscle preservation through resistance training while incorporating cardiovascular exercise for heart health, mood, and additional calorie expenditure. Every recommendation accounts for the unique challenges of exercising during significant caloric deficit.

    Before You Start

    Consult your healthcare provider before beginning any exercise program, especially if you have been sedentary. Start at the beginner level regardless of past fitness experience, as caloric deficit changes your recovery capacity.

    Weekly Exercise Structure

    The optimal weekly plan for retatrutide users includes three types of exercise, each serving a distinct purpose:

    Weekly Schedule Overview

    DayActivityDurationPurpose
    MondayResistance Training (Upper Body)30-45 minMuscle preservation
    TuesdayWalking or Light Cardio30-45 minHeart health, recovery
    WednesdayResistance Training (Lower Body)30-45 minMuscle preservation
    ThursdayRest or Gentle Stretching15-20 minRecovery
    FridayResistance Training (Full Body)30-45 minMuscle preservation
    SaturdayWalking or Moderate Cardio30-60 minCardiovascular fitness
    SundayRest-Full recovery

    Resistance Training: The Non-Negotiable

    Resistance training is the single most important exercise modality for anyone losing weight on GLP-1 medications. It sends a direct signal to your body that muscle tissue is actively needed and should not be broken down for energy. Without this signal, your body has no biological reason to preferentially spare muscle during caloric deficit.

    Upper Body Day (Monday)

    • Chest press or push-ups: 3 sets of 8-12 reps
    • Seated rows or resistance band rows: 3 sets of 8-12 reps
    • Overhead press (dumbbells or machine): 2 sets of 10-12 reps
    • Bicep curls: 2 sets of 10-15 reps
    • Tricep extensions: 2 sets of 10-15 reps

    Lower Body Day (Wednesday)

    • Squats (bodyweight, goblet, or barbell): 3 sets of 8-12 reps
    • Romanian deadlifts: 3 sets of 8-10 reps
    • Leg press or lunges: 3 sets of 10-12 reps per leg
    • Leg curls: 2 sets of 10-15 reps
    • Calf raises: 2 sets of 15-20 reps

    Full Body Day (Friday)

    • Deadlifts or hip hinges: 3 sets of 6-8 reps
    • Bench press or push-ups: 3 sets of 8-12 reps
    • Pull-ups or lat pulldowns: 3 sets of 8-12 reps
    • Goblet squats: 2 sets of 10-12 reps
    • Plank: 2 sets of 30-60 seconds

    Cardiovascular Exercise: Supporting Role

    Cardio plays a supporting role in the retatrutide exercise plan. It supports heart health, improves mood, enhances insulin sensitivity, and provides additional calorie expenditure. However, excessive cardio can accelerate muscle loss during caloric deficit, so moderation is key.

    Cardio Guidelines for Retatrutide Users

    Walking (Best Option)

    30-60 minutes at a moderate pace, 3-5 days per week. Low impact, minimal muscle breakdown, excellent for recovery between resistance sessions.

    Cycling or Swimming

    20-30 minutes at moderate intensity, 2-3 days per week. Low impact alternatives that spare joints while building cardiovascular fitness.

    Avoid Excessive HIIT

    High-intensity interval training places significant demands on recovery. During caloric deficit, recovery capacity is already reduced. Limit HIIT to once per week at most, and only if well-tolerated.

    Progressive Overload: The Key to Results

    The most important principle in resistance training is progressive overload -- gradually increasing the demand on your muscles over time. This does not mean adding weight every session. Progression can come from:

    • Adding repetitions: Going from 8 to 10 to 12 reps with the same weight
    • Adding weight: Increasing by 2.5-5 pounds when you can complete all prescribed reps
    • Adding sets: Going from 2 to 3 sets of an exercise
    • Improving form: Slower, more controlled repetitions increase time under tension
    • Reducing rest: Shorter rest periods (60-90 seconds) increase metabolic demand

    During active weight loss on retatrutide, do not expect rapid strength gains. Maintaining your current strength levels while losing significant body weight is itself a meaningful achievement. If your squat stays at the same weight while you lose 40 pounds of body weight, your relative strength has improved dramatically.

    Exercise Nutrition for Retatrutide Users

    Timing your nutrition around exercise becomes especially important when appetite is suppressed by GLP-1 medications:

    • Pre-workout (1-2 hours before): A small protein-rich snack (Greek yogurt, protein shake) provides amino acids for muscle protection during exercise
    • Post-workout (within 2 hours): 25-30 grams of protein from any source to support muscle protein synthesis. This is the most critical meal of the day for muscle preservation.
    • Hydration: GLP-1 medications can increase dehydration risk. Drink water before, during, and after exercise. Aim for at least 64 ounces daily, more on training days.

    Adjusting for Side Effects and Energy

    Retatrutide can cause nausea, fatigue, and gastrointestinal symptoms, particularly during dose titration. Your exercise plan should adapt:

    • High nausea days: Switch to walking or gentle stretching. Skip intense workouts without guilt.
    • Low energy days: Reduce intensity by 20-30% but still show up. Light resistance training still sends a muscle-preserving signal.
    • Injection day: Schedule your injection for the evening after your workout, or plan a rest day. Most patients find the first 12-24 hours after injection are when side effects peak.
    • Dose increases: Reduce exercise intensity for the first week after each dose increase, then rebuild.

    To explore currently available weight loss treatment options and discuss an exercise plan with a provider, visit our treatments page.

    Medical Disclaimer

    This article is for educational purposes only and does not constitute medical advice. Retatrutide is an investigational drug not yet approved by the FDA. Exercise recommendations are general guidelines and should be individualized by a healthcare provider or certified fitness professional. Clinical data referenced is from Phase 2 trials (Jastreboff et al., NEJM 2023). Consult with a licensed healthcare provider before starting any exercise program or weight loss medication.

    Start Your Weight Loss Journey

    Expert medical guidance paired with lifestyle support. Get matched with a provider today.

    Get Started Today

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    What does the published clinical evidence show for retatrutide?

    Peer-reviewed evidence: Retatrutide 12 mg produced a mean body weight reduction of approximately 24.2% at 48 weeks in adults with obesity in a Phase 2 trial, the highest published mean weight reduction for any GLP-1-class agent in obesity to date. (Source: Jastreboff et al. Phase 2 trial, NEJM 2023). Trimi is preparing for launch; compounded availability depends on FDA-cleared compounding pathways. Results vary by individual; eligibility is determined by a licensed clinician.

    Retatrutide 12 mg produced a mean body weight reduction of approximately 24.2% at 48 weeks in adults with obesity in a Phase 2 trial, the highest published mean weight reduction for any GLP-1-class agent in obesity to date., Jastreboff et al. Phase 2 trial, NEJM 2023
    Retatrutide 12 mg reduced HbA1c by approximately 2.02 percentage points at 36 weeks in patients with type 2 diabetes, compared with 1.41 points on dulaglutide 1.5 mg., Rosenstock et al. Phase 2 T2D trial, Lancet 2023

    Key Takeaways

    • Retatrutide 12 mg produced a mean body weight reduction of approximately 24.2% at 48 weeks in adults with obesity in a Phase 2 trial, the highest published mean weight reduction for any GLP-1-class agent in obesity to date. (Source: Jastreboff et al. Phase 2 trial, NEJM 2023)
    • Retatrutide 12 mg reduced HbA1c by approximately 2.02 percentage points at 36 weeks in patients with type 2 diabetes, compared with 1.41 points on dulaglutide 1.5 mg. (Source: Rosenstock et al. Phase 2 T2D trial, Lancet 2023)
    • Retatrutide is investigational and not FDA-approved as of publication. Trial findings reported here are from Phase 2 / Phase 3 studies in peer-reviewed sources cited below.
    • Eligibility requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: December 1, 2025

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    - Veronica LarimoreFacebook
    It's only been 2 weeks since I've been taking the VialsRx meds from Trimi. The medication showed up pretty quickly (about 4 days after getting approval from Trimi prescriber) and I received 3 vials for my first 3 months on the subscription. For the price and convenience my take is that Trimi and VialsRx is good.

    Outcome: 4-day delivery; 3 vials for first 3 months; price + convenience verdict positive

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Jastreboff AM, Kaplan LM, Frías JP, et al. (2023). Triple-Hormone-Receptor Agonist Retatrutide for Obesity, A Phase 2 Trial. New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2301972
    2. Rosenstock J, Frias J, Jastreboff AM, et al. (2023). Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial. The Lancet.Read StudyDOI: 10.1016/S0140-6736(23)01053-X
    3. ClinicalTrials.gov (2024). A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Are Overweight (TRIUMPH-1), NCT05929066. ClinicalTrials.gov.Read Study
    4. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    5. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    6. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    What to expect in your first month on retatrutide: realistic weight loss expectations, side effects, appetite changes, and tips for maximizing early results during the dose titration phase.

    Step-by-step retatrutide injection: 6-day half-life, once-weekly dosing, site rotation, and how to time shots for fewer side effects and better weight loss results.

    Week-by-week weight loss expectations on retatrutide. Understand the typical trajectory from first injection through 48 weeks, including acceleration phases, plateaus, and realistic weekly targets.

    Understanding sarcopenia risk during retatrutide weight loss. Learn how to assess, prevent, and manage age-related muscle loss while taking the triple agonist, with specific guidelines for older adult

    Start your GLP-1 journey, from $99/mo

    Get Started